Azamian Bobak R. 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Mar 26, 2025
Insider Transaction Report
Form 4
Azamian Bobak R.
DirectorPresident/CEO and Board Chair
Transactions
- Sale
Common Stock
2025-03-24$50.00/sh−6,000$300,000→ 824,106 total(indirect: By Trust)
Holdings
- 53,635
Common Stock
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2024.
- [F2]The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.